Critical Care News and Research

RSS

Well-designed electronic alerts improve care for cardiac patients

For busy health care workers, the electronic health record (EHR) can feel like an endless stream of clicks and prompts.

6 Oct 2026

Short-term vaping exposure injures deep lung tissue and immunity

Just days of e-cigarette vapor exposure can injure the lungs' most delicate tissue and leave it more vulnerable to viral infection, according to a study led by National Jewish Health researchers and published in JCI Insight.

6 Oct 2026

UVM receives historic contract to develop medical digital twins

What if doctors could test a customized treatment on a virtual version of a critically ill patient before administering it in real life? That's the promise of medical "digital twins."

30 Sep 2026

New proclamation highlights respiratory health awareness across Phoenix, Arizona

At the request of the American College of Chest Physicians (CHEST), the City of Phoenix and Mayor Kate Gallego officially proclaimed October 18, 2026, as Love Your Lungs Day for Phoenix, Arizona.

29 Sep 2026

Veterinary sedative in fentanyl supply spikes severe withdrawal cases

A powerful veterinary sedative, medetomidine, is increasingly infiltrating the street supplies of the already deadly opioid fentanyl, with patients suffering from its withdrawal quadrupling in recent years, according to a new analysis by researchers at the Perelman School of Medicine at the University of Pennsylvania.

29 Sep 2026

Intentional substance exposures at school rise sharply among younger children

A new study found that rates of intentional substance exposures at school reported to U.S. poison centers increased substantially among elementary- and middle-school-aged children from 2000 through 2024, while high-school-aged adolescents continued to experience the highest rates of serious medical outcomes and hospital admissions.

28 Sep 2026

AI tool provides early warning for organ failure in acute pancreatitis

Acute pancreatitis (AP) is one of the most common acute digestive disorders worldwide, and its most feared complication-persistent organ failure-drives mortality rates of 30% to 50%.

24 Sep 2026

New slow-release drug delivery system provides weeks of pain-numbing anesthetic effects

Most local anesthetics used in medicine only last eight to 12 hours or a day tops. Now Boston Children's Hospital researchers have formulated a more effective slow-release injectable drug delivery system that achieved pain-numbing anesthetic effects lasting two to three weeks in rats compared to a commercial formulation lasting about four to eight hours.

23 Sep 2026

New national guidelines developed to improve sepsis-related care

A UVA Health doctor and other leading national experts have developed important new guidelines to improve care for patients who develop sepsis, a dangerous full-body infection that kills at least 350,000 Americans every year.

18 Sep 2026

New clinical guidelines standardize kidney replacement therapy in ICU patients

Acute kidney injury (AKI) is a common and severe complication in the intensive care unit (ICU). Due to its high incidence, strong correlation with poor prognosis, and substantial consumption of medical resources, AKI has become one of the central challenges in modern critical care medicine.

17 Sep 2026

ACC Latin America 2026 brings together experts to examine the latest cardiovascular science

The American College of Cardiology (ACC) and the Colombian Society of Cardiology and Cardiovascular Surgery will host the ACC Latin America 2026 conference on September 17-19 in Medellín, Colombia.

9 Sep 2026

Johns Hopkins researchers identify human resistin as a key driver of inflammation

Researchers at Johns Hopkins Medicine have uncovered a critical biological mechanism that helps explain how inflammation is triggered and sustained in a wide range of diseases-highlighting a promising avenue for future therapeutic development.

9 Sep 2026

New biologic therapy significantly reduces COPD flare-ups in trials

Two international clinical trials led in part by researchers at the University of Pittsburgh School of Medicine found that the investigational biologic therapy tozorakimab significantly reduced chronic obstructive pulmonary disease (COPD) flare-ups among patients already receiving standard treatment for the disease compared to patients only receiving standard treatment.

8 Sep 2026

Genetic marker links popular seizure drug to life-threatening reaction

A genetic marker already used to flag risk of a life-threatening reaction to the antibiotic vancomycin also identifies patients at risk of that reaction to lamotrigine - and it is missing from the gene panels clinicians order before prescribing the drug, Vanderbilt Health-led researchers report Sept. 2 in JAMA Network Open.

2 Sep 2026